State of Michigan Retirement System’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,765
Closed -$554K 985
2021
Q2
$554K Sell
6,765
-3,045
-31% -$253K ﹤0.01% 946
2021
Q1
$933K Buy
9,810
+481
+5% +$45.5K 0.01% 924
2020
Q4
$579K Hold
9,329
﹤0.01% 944
2020
Q3
$555K Hold
9,329
﹤0.01% 909
2020
Q2
$651K Buy
9,329
+1,955
+27% +$124K 0.01% 862
2020
Q1
$335K Sell
7,374
-962
-12% -$54.5K ﹤0.01% 883
2019
Q4
$542K Sell
8,336
-481
-5% -$32.1K ﹤0.01% 906
2019
Q3
$547K Sell
8,817
-480
-5% -$30.1K 0.01% 887
2019
Q2
$662K Sell
9,297
-2,405
-21% -$177K 0.01% 864
2019
Q1
$918K Sell
11,702
-481
-4% -$36.4K 0.01% 839
2018
Q4
$1.03M Buy
+12,183
New +$1.3M 0.01% 770

Other funds holding LGND

State of Michigan Retirement System's LGND Position: Q3 2021 in Review

State of Michigan Retirement System sold out of Ligand Pharmaceuticals (LGND) in Q3 2021, closing a stake of 6,765 shares — an estimated $554K sold.

State of Michigan Retirement System first reported a position in LGND in Q4 2018 and held it in 11 quarters. The position peaked at $1.03M in Q4 2018. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.

  • State of Michigan Retirement System reported no remaining Ligand Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • State of Michigan Retirement System sold 6,765 Ligand Pharmaceuticals shares in Q3 2021, an estimated $554K.
  • State of Michigan Retirement System first reported a position in Ligand Pharmaceuticals in Q4 2018 and held it in 11 quarters.
  • State of Michigan Retirement System's Ligand Pharmaceuticals position peaked at $1.03M in Q4 2018.
  • 207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.

Based on State of Michigan Retirement System's 13F filing for Q3 2021, filed 27 Oct 2021.